The author presents a totally biological solution for aortomitral endocarditis by combining AVNeo™ (Ozaki procedure) and transaortic mitral valve patch using autologous pericardium only.
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
AVNeo™ (Ozaki) and Transaortic Mitral Valve Repair Using Autologous Pericardium Only for Aortomitral Endocarditis
July 7, 2020
Design, Development, Testing at ISO Standards and In Vivo Feasibility Study of a Novel Polymeric Heart Valve Prosthesis
June 30, 2020
Researchers from the UK reported a novel polymeric heart valve, PoliValve, which is made entirely from styrenic block copolymers.
Reoperation After Transcatheter Aortic Valve Replacement: An Analysis of the Society of Thoracic Surgeons Database
June 11, 2020
As TAVR is used in progressively lower-risk cohorts, management of device failure will become increasingly important. This study reports the largest series of patients receiving a surgical reoperation after transcatheter aortic valve replacement (TAVR) using the STS Adult Cardiac Surgery Database.
A New Role for the Aldosterone/Mineralocorticoid Receptor Pathway in the Development of Mitral Valve Prolapse
May 11, 2020
Interesting hypothesis in a rodent model of myxomatous degeneration.
March 22, 2020
Leanne Harling interviews John McKenna about his experience in the device industry side of cardiothoracic surgery.
March 1, 2020
A very easy-to-read editorial that digests a manuscript on the IMPROVE study.
February 26, 2020
Five year results of the PARTNER II trial demonstrated no difference in the risk of stroke or death comparing TAVR to surgical aortic valve replacement among intermediate surgical risk patients.
Edwards Lifesciences' Every Heartbeat Matters Philanthropic Initiative Expanding To Reach More Patients
February 24, 2020
In 2014, Edwards Lifescience launched an ambitious philanthropic initiative called Every Heartbeat Matters (EHM) with the goal of impacting the global burden of heart valve disease through the education, screening and treatment of 1 million underserved people by 2020.
February 3, 2020
Use of a novel decision aid for patients with symptomatic aortic stenosis resulted in greater patient knowledge and satisfaction, although decisional conflict was unchanged. Physicians, on the other hand, felt that the aid was not understood by elderly patients, and believed that they used shared decision-making in their usual practice, without the
January 23, 2020
In this Giants of Cardiothoracic Surgery interview, Joel Dunning speaks with James L. Cox, creator of the Cox maze procedure for the treatment of atrial fibrillation.